Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
Open Access
- 12 June 2024
- journal article
- research article
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (2) , 151-156
Abstract
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease. Despite some encouraging studies of pharmacological treatments, the development of hepatorenal syndrome in people with cirrhosis implies a poor prognosis, as renal failure is usually irreversible unless a liver transplantation is performed. The purpose is to show the peculiarities of hepatorenal syndrome and the method of its successful treatment. The article describes a clinical case of hepatorenal syndrome in the postoperative period in a 54-year-old woman who was hospitalized urgently with bleeding esophageal varices. She has a history of liver cirrhosis associated with HCV and portal vein thrombosis, portal hypertension syndrome, bleeding esophageal varices, ascites. After stabilization of hemodynamic parameters, the patient underwent a portoazygous disconnection, which included devascularization of the distal esophagus, proximal stomach, and esophageal transection. The first day of the postoperative period was complicated by the development of hepatorenal syndrome. Only its timely diagnosis in decompensated portal hypertension, with the elimination of pathophysiological components of the pathological process, allows correcting this complex pathology. When draining ascites, detoxification of the body is possible, which makes it possible to partially compensate for impaired kidney function. Albumin replacement therapy helps maintain osmotic balance.Keywords
This publication has 23 references indexed in Scilit:
- Diagnosis and Management of Cirrhosis and Its ComplicationsJAMA, 2023
- Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injuryHepatology, 2023
- AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert ReviewClinical Gastroenterology and Hepatology, 2022
- Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventJHEP Reports, 2022
- Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trialsJGH Open, 2021
- Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine‐Based and Cystatin C–Based Equations: Systematic Review and Meta‐AnalysisLiver Transplantation, 2021
- Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2021
- Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with CirrhosisClinics in Liver Disease, 2021
- News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus documentJournal of Hepatology, 2019
- Significance of oliguria in critically ill patients with chronic liver diseaseHepatology, 2017